CLINICAL_TRIALS trial_result · 2022-02-03

Clinical Trial Update: Evaluation of the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (the RAINIER Study) [Phase 2]

Phase 2 trial evaluating OC-02 nasal spray for dry eye disease has completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Oyster Point Pharma, Inc. | Conditions: Dry Eye Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-02-03